Your browser doesn't support javascript.
loading
Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience.
Wang, Yu-Wen; Tsai, Xavier Cheng-Hong; Hou, Hsin-An; Tien, Feng-Ming; Liu, Jia-Hau; Chou, Wen-Chien; Ko, Bor-Sheng; Chen, Yu-Wen; Lin, Chien-Chin; Cheng, Chieh-Lung; Lo, Min-Yen; Lin, Yun-Chu; Lu, Li-Chun; Wu, Shang-Ju; Kuo, Sung-Hsin; Hong, Ruey-Long; Huang, Tai-Chung; Yao, Ming.
Afiliação
  • Wang YW; Department of Pharmacy, National Taiwan University Hospital, Taipei, Taiwan.
  • Tsai XC; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. xavierchtsai@ntu.edu.tw.
  • Hou HA; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Tien FM; Department of Hematological Oncology, National Taiwan University Cancer Center, National Taiwan University Hospital, Taipei, Taiwan.
  • Liu JH; Department of Hematological Oncology, National Taiwan University Cancer Center, National Taiwan University Hospital, Taipei, Taiwan.
  • Chou WC; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Ko BS; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Chen YW; Department of Hematological Oncology, National Taiwan University Cancer Center, National Taiwan University Hospital, Taipei, Taiwan.
  • Lin CC; Department of Pharmacy, National Taiwan University Hospital, Taipei, Taiwan.
  • Cheng CL; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Lo MY; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Lin YC; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Lu LC; Department of Hematological Oncology, National Taiwan University Cancer Center, National Taiwan University Hospital, Taipei, Taiwan.
  • Wu SJ; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
  • Kuo SH; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Hong RL; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
  • Huang TC; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
  • Yao M; Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Ann Hematol ; 101(2): 349-358, 2022 Feb.
Article em En | MEDLINE | ID: mdl-34766217
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Imunoconjugados / Anticorpos Monoclonais / Recidiva Local de Neoplasia Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Taiwan
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Imunoconjugados / Anticorpos Monoclonais / Recidiva Local de Neoplasia Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Taiwan